These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 17112862)

  • 1. Tamoxifen therapy in encapsulating sclerosing peritonitis in patients after kidney transplantation.
    Moustafellos P; Hadjianastassiou V; Roy D; Velzeboer NE; Maniakyn N; Vaidya A; Friend PJ
    Transplant Proc; 2006 Nov; 38(9):2913-4. PubMed ID: 17112862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sclerosing encapsulating peritonitis secondary to CAPD: the effect of fibrotic debridement on further dialysis.
    Klimopoulos S; Katsoulis IE; Margellos V; Nikolopoulou N
    J R Coll Surg Edinb; 2002 Apr; 47(2):485-90. PubMed ID: 12018692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sclerosing encapsulating peritonitis in a child secondary to peritoneal dialysis.
    Tan FL; Loh D; Prabhakaran K
    J Pediatr Surg; 2005 May; 40(5):e21-3. PubMed ID: 15937801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tamoxifen therapy in kidney-transplant patients presenting with severe encapsulating peritoneal sclerosis after treatment for acute humoral rejection.
    Mohamed AO; Kamar N; Nogier MB; Esposito L; Duffas JP; Rostaing L
    Exp Clin Transplant; 2009 Sep; 7(3):164-7. PubMed ID: 19715526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous ambulatory peritoneal dialysis and sclerosing encapsulating peritonitis: tamoxifen as a new therapeutic agent?
    Allaria PM; Giangrande A; Gandini E; Pisoni IB
    J Nephrol; 1999; 12(6):395-7. PubMed ID: 10626830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sclerosing peritonitis with mural bowel fibrosis in a patient on long-term CAPD.
    Hauglustaine D; van Meerbeek J; Monballyu J; Goddeeris P; Lauwerijns J; Michielsen P
    Clin Nephrol; 1984 Sep; 22(3):158-62. PubMed ID: 6488597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Implementing HPN in an SEP case following long-term CAPD].
    Kaneko K; Hidaka K; Koyama K; Ishii J; Yokota S; Ouchi T
    Gan To Kagaku Ryoho; 1998 Dec; 25 Suppl 4():589-94. PubMed ID: 9884646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical treatment for sclerosing encapsulating peritonitis.
    Kawanishi H; Harada Y; Sakikubo E; Moriishi M; Nagai T; Tsuchiya S
    Adv Perit Dial; 2000; 16():252-6. PubMed ID: 11045305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppression in sclerosing peritonitis.
    Junor BJ; McMillan MA
    Adv Perit Dial; 1993; 9():187-9. PubMed ID: 8105920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sclerosing encapsulating peritonitis: a case series from a single U.K. center during a 10-year period.
    Jenkins SB; Leng BL; Shortland JR; Brown PW; Wilkie ME
    Adv Perit Dial; 2001; 17():191- 5. PubMed ID: 11510272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sclerosing peritonitis].
    Michel C; Hufnagel G; Niang A; Shkiri H; Queffeulou G; Vrtovsnik F; Mignon F
    Nephrologie; 2001; 22(4):141-8. PubMed ID: 11488168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis for patients with sclerosing encapsulating peritonitis following CAPD.
    Yokota S; Kumano K; Sakai T
    Adv Perit Dial; 1997; 13():221-3. PubMed ID: 9360686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sclerosing peritonitis.
    Bowers VD; Ackermann JR; Richardson W; Carey LC
    Clin Transplant; 1994 Aug; 8(4):369-72. PubMed ID: 7949541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gross calcification of the small bowel in a continuous ambulatory peritoneal dialysis patient with sclerosing peritonitis.
    Poultsidi A; Liakopoulos V; Eleftheriadis T; Zarogiannis S; Bouchlariotou S; Stefanidis I
    Adv Perit Dial; 2006; 22():104-7. PubMed ID: 16983950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laparoscopy in the early diagnosis and management of sclerosing encapsulating peritonitis.
    Kropp J; Sinsakul M; Butsch J; Rodby R
    Semin Dial; 2009; 22(3):304-7. PubMed ID: 19386074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical evaluation of cases with massive ascites accumulation after discontinuation of CAPD: an attempt to establish the concept of the pre-sclerosing encapsulating peritonitis(pre-SEP) state].
    Kasai K; Terawaki H; Otsuka Y; Hamaguchi A; Kondo M; Tanno Y; Hara Y; Ichinose M; Kawaguchi Y; Hosoya T
    Nihon Jinzo Gakkai Shi; 2000 May; 42(4):346-52. PubMed ID: 10897594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment options for encapsulating peritoneal sclerosis based on progressive stage.
    Kawanishi H; Harada Y; Noriyuki T; Kawai T; Takahashi S; Moriishi M; Tsuchiya S
    Adv Perit Dial; 2001; 17():200-4. PubMed ID: 11510276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with tamoxifen in peritoneal fibrosing syndromes.
    del Peso G; Bajo MA; Gil F; Aguilera A; Ros S; Costero O; Castro MJ; Selgas R
    Adv Perit Dial; 2003; 19():32-5. PubMed ID: 14763031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous ambulatory peritoneal dialysis (CAPD) policy for renal transplantations in adults.
    Shiramizu T; Satoh T; Jinushi K; Oka N; Inokuchi K
    Tokai J Exp Clin Med; 1986 Oct; 11(4):255-6. PubMed ID: 3303455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sclerosing encapsulating peritonitis: a latent threat. Changes of posture in surgery treatment].
    Herrero JC; Molina A; Lentisco C; García C; Ortiz M; Mon C; Ortega O; Rodríguez I; Oliet A; Vigil A; Gallar P
    Nefrologia; 2007; 27(6):729-36. PubMed ID: 18336103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.